Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification

被引：0
|
作者：
Gasior, A. [1 ]
Gorniak, J. [1 ]
Rollinson, S. [1 ]
Gough, L. [1 ]
Wegscheider, A. [2 ]
Niendorf, A. [2 ]
机构：
[1] APIS Assay Technol, Manchester, Lancs, England
[2] MVZ Prof Dr Med A Niendorf Pathol Hamburg West Gm, Hamburg, Germany
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST047
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 "Ultra-Low" Setting: Implications for Precision Therapy in HER2-Breast Cancer
    Petricoin, Emanuel F.
    Corgiat, Brian A.
    O'Shaughnessy, Joyce
    LoRusso, Patricia
    Weinberg, Kris
    Davis, Justin
    Gawryletz, Chelsea
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [43] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Dupouy, D.
    Ciftlik, A. T.
    Fiche, M.
    Heintze, D.
    Bisig, B.
    de Leval, L.
    Gijs, M. A. M.
    VIRCHOWS ARCHIV, 2016, 469 : S21 - S21
  • [44] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Dupouy, Diego G.
    Ciftlik, Ata Tuna
    Fiche, Maryse
    Heintze, Deborah
    Bisig, Bettina
    de Leval, Laurence
    Gijs, Martin A. M.
    SCIENTIFIC REPORTS, 2016, 6
  • [45] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Diego G. Dupouy
    Ata Tuna Ciftlik
    Maryse Fiche
    Déborah Heintze
    Bettina Bisig
    Laurence de Leval
    Martin A. M. Gijs
    Scientific Reports, 6
  • [46] Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.
    Antolin, Silvia
    Garcia-Caballero, Lucia
    Reboredo, Cristina
    Molina Diaz, Aurea
    Mosquera, Joaquin
    Vazquez-Boquete, Angel
    Gallego, Rosalia
    Paz Santiago, Maria
    Concha, Angel
    Eva Perez, Maria
    Calvo, Lourdes
    Garcia-Caballero, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Impact of HER2 Copy Number in IHC HER2 2+/FISH Positive Breast Cancer on Outcome of Adjuvant Trastuzumab Treatment
    Borley, A.
    Mercer, T.
    Morgan, M.
    Barrett-Lee, P.
    Jasani, B.
    JOURNAL OF PATHOLOGY, 2013, 231 : 19 - 19
  • [48] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [49] Testing for HER2 in breast cancer
    Lewis, F
    Jackson, P
    Lane, S
    Coast, G
    Hanby, AM
    HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
  • [50] HER2 Signaling in Breast Cancer
    Shin, Incheol
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 53 - 79
12345